2022.06.16IR

Notice Regarding Posting of Non-operating Income

2022.05.11IR

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan

2022.05.10IR

Consolidated Financial Report for the First Quarter 2022

2022.03.11IR

Notice of the 23rd Annual General Meeting of Shareholders

2022.02.16Information

Announcement U.S. Subsidiary (AnGes USA, Inc.) Office Relocation and the Appointment of Mr. Masami Yuhara as the CEO of AnGes USA, Inc.

Learn more